Antiviral therapy in viral heart disease;Antivirale therapie bei viraler herzerkrankung

Herz

Volumn 29, Issue 6, 2004, Pages 618-623

  Pauschinger, Matthias ^a   Noutsias, Michel ^a   Kühl, Uwe ^a   Schultheiss, Heinz Peter ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

interferon; Dilated Cardiomyopathy; Inflammation; Myocarditis; Viral heart disease

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA INTERFERON; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; INTERFERON BETA SERINE; SPIRONOLACTONE;

ADENOVIRUS; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; DIFFERENTIAL DIAGNOSIS; DRUG EFFICACY; ENTEROVIRUS; EPSTEIN BARR VIRUS; HEART FAILURE; HUMAN; HUMAN HERPESVIRUS 6; IN SITU HYBRIDIZATION; MOLECULAR BIOLOGY; NESTED POLYMERASE CHAIN REACTION; PARVOVIRUS; PERSISTENT VIRUS INFECTION; POLYMERASE CHAIN REACTION; REVIEW; VIRUS DETECTION; VIRUS GENOME; VIRUS MYOCARDITIS;

ANTIVIRAL AGENTS; CARDIOMYOPATHY, DILATED; HUMANS; INTERFERON-BETA; MYOCARDITIS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; VIRUS DISEASES;

EID: 5444236811     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00059-004-2598-9     Document Type: Review

References (46)

1. Aretz HT. Myocarditis: the Dallas criteria. Hum Pathol 1987;18:619-24.
2. Baboonian C, Treasure T. Meta-analysis of the association of enteroviruses with human heart disease. Heart 1997;78:539-43.
3. Badorff C, Lee GH, Lamphear BJ, et al. Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy. Nat Med 1999;5:320-6.
4. Bowles NE, Fuentes-Garcia FJ, Makar KA, et al. Analysis of the coxsackievirus B-adenovirus receptor gene in patients with myocarditis or dilated cardiomyopathy. Mol Genet Metab 2002;77:257-9.
5. Bowles NE, Ni J, Kearney DL, et al. Detection of viruses in myocardial tissues by polymerase chain reaction, evidence of adenovirus as a common cause of myocarditis. J Am Coll Cardiol 2003;42:466-72.
6. Bowles NE, Ni J, Marcus F, et al. The detection of cardiotropic viruses in the myocardium of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol 2002;39:892-5.
7. Bultmann BD, Klingel K, Sotlar K, et al. Parvovirus Big: a pathogen responsible for more than hematologic disorders. Virchows Arch 2003;442:8-17.
8. Caforio AL, Keeling PJ, Zachara E, et al. Evidence from family studies for auto-immunity in dilated cardiomyopathy. Lancet 1994;344:773-7.
9. Carlquist JF, Menlove RL, Murray MB, et al. HLA class II (DR and DO) antigen associations in idiopathic dilated cardiomyopathy. Validation study and meta-analysis of published HLA association studies. Circulation 1991;83:515-22.
10. D'Ambrosio A, Patti G, Manzoli A, et al. The fate of acute myocarditis between spontaneous improvement and evolution to dilated cardiomyopathy: a review. Heart 2001;85:499-504.
11. Felix SB, Staudt A, Dorffel WV, et al. Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy: three-month results from a randomized study. J Am Coll Cardiol 2000;35:1590-8.
12. Frustaci A, Chimenti C, Calabrese F, et al. Immunosuppressive therapy for active lymphocytic myocarditis. Virological and immunological profile of responders versus nonresponders. Circulation 2003;107:857-63.
13. Gauntt CJ, Arizpe HM, Higdon AL, et al. Molecular mimicry, anti-coxsackie-virus B3 neutralizing monoclonal antibodies, and myocarditis. J Immunol 1995;154:2983-95.
14. Hauck AJ, Kearney DL, Edwards WD. Evaluation of postmortem endomyocardial biopsy specimens from 38 patients with lymphocytic myocarditis: implications for role of sampling error. Mayo Clin Proc 1989;64:1235-45.
15. Ino T, Kishiro M, Okubo M, et al. Late persistent expressions of ICAM-1 and VCAM-1 on myocardial tissue in children with lymphocytic myocarditis. Cardiovasc Res 1997;34:323-8.
16. Jin O, Sole MJ, Butany JW, et al. Detection of enterovirus RNA in myocardial biopsies from patients with myocarditis and cardiomyopathy using gene amplification by polymerase chain reaction. Circulation 1990;82:8-16.
17. Kandolf R, Klingel K, Zell R, et al. Molecular pathogenesis of enterovirus-induced myocarditis: virus persistence and chronic inflammation. Intervirology 1993;35:140-51.
18. Kuhl U, Noutsias M, Seeberg B, et al. Immunohistological evidence for a chronic intramyocardial inflammatory process in dilated cardiomyopathy. Heart 1996;35:295-300.
19. Kuhl U, Pauschinger M, Bock T, et al. Parvovirus B19 infection mimicking acute myocardial infarction. Circulation 2003;108:945-50.
20. Kuhl U, Pauschinger M, Schwimmbeck PL, et al. Interferon β treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genome and left ventricular dysfunction. Circulation 2003;107:2793-8.
21. Kuhl U, Schultheiss HP. Treatment of chronic myocarditis with corticosteroids. Eur Heart J 1995;16:168-72.
22. Liu PP, Mason JW. Advances in the understanding of myocarditis. Circulation 2001;104:1076-82.
23. Mahon NG, Hamid S, McKenna WJ. Prevalence and natural history of dilated cardiomyopathy. Int J Cardiol 2000;75:158-9.
24. Mahon NG, Madden BP, Caforio AL, et al. Immunohistologic evidence of myocardial disease in apparently healthy relatives of patients with dilated cardiomyopathy. J Am Coll Cardiol 2002;39:455-62.
25. Mahon NG, Zal B, Arno G, et al. Absence of viral nucleic acids in early and late dilated cardiomyopathy. Heart 2001;86:687-92.
26. Matsumori A. Cytokines in myocarditis and cardiomyopathies. Curr Opin Cardiol 1996;11:302-9.
27. McKenna CJ, Codd MB, McCann HA, et al. Idiopathic dilated cardiomyopathy: familial prevalence and HLA distribution. Heart 1997;77:549-52.
28. Noutsias M, Fechner H, de Jonge H, et al. Human coxsackie-adenovirus receptor is colocalized with integrins alpha(v)beta(3) and alpha(v)beta(5) on the cardiomyocyte sarcolemma and upregulated in dilated cardiomyopathy: implications for cardiotropic viral infections. Circulation 2001:104:275-80.
29. Noutsias M, Pauschinger M, Ostermann K, et al. Digital image analysis system for the quantification of infiltrates and cell adhesion molecules in inflammatory cardiomyopathy. Med Sci Monit 2002;8:59-71.
30. Noutsias M, Pauschinger M, Poller WC, et al. Current insights into the pathogenesis, diagnosis and therapy of inflammatory cardiomyopathy. Heart Fail Monit 2003;3:127-35.
31. Noutsias M, Pauschinger M, Schultheiss HP, et al. Phenotypic characterization of infiltrates in dilated cardiomyopathy - diagnostic significance of T-lymphocytes and macrophages in inflammatory ca rdiomyopathy. Med Sci Monit 2002;8:478-87.
32. Noutsias M, Pauschinger M, Schultheiss HP, et al. Cytotoxic perforin+ and TIA-1+ infiltrates are associated with cell adhesion molecule expression in dilated cardiomyopathy. Eur J Heart Fail 2003;5:469-79.
33. Noutsias M, Seeberg B, Schultheiss HP, et al. Expression of cell adhesion molecules in dilated cardiomyopathy: evidence for endothelial activation in inflammatory cardiomyopathy. Circulation 1999;99:2124-31.
34. Olbrich HG. [Epidemiology-etiology of dilated cardiomyopathy.] Z Kardiol 2001;90:Suppl 1:2-9.
35. Pankuweit S, Moll R, Baandrup U, et al. Prevalence of the parvovirus Big genome in endomyocardial biopsy specimens. Hum Pathol 2003;34:497-503.
36. Pauschinger M, Bowles NE, Fuentes-Garcia FJ, et al. Detection of adenoviral genome in the myocardium of adult patients with idiopathic left ventricular dysfunction. Circulation 1999;99:1348-54.
37. Pauschinger M, Doerner A, Kuehl U, et al. Enteroviral RNA replication in the myocardium of patients with left ventricular dysfunction and clinically suspected myocarditis. Circulation 1999;99:889-95.
38. Pauschinger M, Knopf D, Petschauer S, et al. Dilated cardiomyopathy is associated with significant changes in collagen type I/III ratio. Circulation 1999;99:2750-6.
39. Richardson P, McKenna W, Bristow M, et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies [News]. Circulation 1996;93:841-2.
40. Rohayem J, Dinger J, Fischer R, et al. Fatal myocarditis associated with acute parvovirus Big and human herpesvirus 6 coinfection. J Clin Microbiol 2001;39:4585-7.
41. Strauer BE, Kandolf R, Mall G, et al. [Update 2001. Myocarditis - cardiomyopathy.] Med Klin 2001;96:608-25.
42. Sugrue DD, Rodeheffer RJ, Codd MB, et al. The clinical course of idiopathic dilated cardiomyopathy. A population-based study. Ann Intern Med 1992;117:117-23.
43. Wessely R, Henke A, Zell R, et al. Low-level expression of a mutant coxsackieviral cDNA induces a myocytopathic effect in culture: an approach to the study of enteroviral persistence in cardiac myocytes. Circulation 1998;98:450-7.
44. Why HJ, Meany BT, Richardson PJ, et al. Clinical and prognostic significance of detection of enteroviral RNA in the myocardium of patients with myocarditis or dilated cardiomyopathy. Circulation 1994;89:2582-9.
45. Wojnicz R, Nowalany-Kozielska E, Wodniecki J, et al. Immunohistological diagnosis of myocarditis. Potential role of sarcolemmal induction of the MHC and ICAM-1 in the detection of autoimmune mediated myocyte injury. Eur Heart J 1998;19:1564-72.
46. Wojnicz R, Nowalany-Kozielska E, Wojciechowska C, et al. Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results. Circulation 2001;104:39-45.